LPC
Lion Point Capital Portfolio holdings
AUM
$14.7M
This Quarter Return
+1.28%
1 Year Return
+16.78%
3 Year Return
+52.25%
5 Year Return
+189.95%
10 Year Return
–
AUM
$52.3M
AUM Growth
-$59.7M
(-53%)
Cap. Flow
-$70.6M
Cap. Flow
% of AUM
-134.94%
Top 10 Holdings %
Top 10 Hldgs %
83.74%
Holding
36
New
6
Increased
5
Reduced
4
Closed
6
Top Buys
| 1 |
Geron
GERN
|
$1.98M |
| 2 |
Milestone Pharmaceuticals
MIST
|
$1.16M |
| 3 |
Neurocrine Biosciences
NBIX
|
$1.03M |
| 4 |
Jasper Therapeutics
JSPR
|
$940K |
| 5 |
Mineralys Therapeutics
MLYS
|
$775K |
Top Sells
| 1 |
Semtech
SMTC
|
$70.9M |
| 2 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$2.6M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$1.95M |
| 4 |
Battalion Oil
BATL
|
$1.14M |
| 5 |
Ardelyx
ARDX
|
$767K |
Sector Composition
| 1 | Healthcare | 57.04% |
| 2 | Consumer Discretionary | 3.03% |
| 3 | Financials | 1.62% |
| 4 | Energy | 0.22% |
| 5 | Technology | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class C
GOOG
$2.79T
| $15.2K | 0.01% |
100
| – | – |
|
|
27
Semtech
SMTC
$5.03B
| $385 | ﹤0.01% |
14
-2,577,841
| -100% | -$70.9M |
|
28
Aclaris Therapeutics
ACRS
$223M
| – | – |
-115,898
| Closed | -$122K |
|
29
Amylyx Pharmaceuticals
AMLX
$877M
| – | – |
-14,000
| Closed | -$206K |
|
30
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
0
| – | – |
|
31
Mirum Pharmaceuticals
MIRM
$3.75B
| – | – |
-13,500
| Closed | -$399K |
|
32
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
|
WHWK
33
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| – | – |
-82,423
| Closed | -$166K |
|
|
CBAY
34
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-82,425
| Closed | -$1.95M |
|
|
HARP
35
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – |
-228,900
| Closed | -$2.6M |
|